Aion Therapeutic Inc.
ANTCF
$0.0055
-$0.001-15.39%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -426.80K | -270.80K | -3.98M | -279.90K | -133.60K |
| Total Depreciation and Amortization | 20.90K | 20.90K | 20.00K | 11.10K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.70K | 38.30K | 3.64M | 35.40K | 21.50K |
| Change in Net Operating Assets | 250.60K | -186.40K | -277.10K | 413.60K | 79.80K |
| Cash from Operations | -108.60K | -398.00K | -596.10K | 180.20K | -32.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -17.30K | -148.20K |
| Cash from Investing | -- | -- | 0.00 | -17.30K | -148.20K |
| Total Debt Issued | 0.00 | 415.20K | 0.00 | 35.00K | -- |
| Total Debt Repaid | -165.00K | -46.20K | -20.70K | -12.20K | -- |
| Issuance of Common Stock | 242.00K | 200.00K | 550.00K | 0.00 | 387.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -300.00 | 25.90K | -- |
| Cash from Financing | 56.40K | 415.60K | 389.80K | 36.10K | 285.40K |
| Foreign Exchange rate Adjustments | 61.60K | -8.40K | -700.00 | 59.10K | -129.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.30K | 9.20K | -207.00K | 258.00K | -24.30K |
